These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 5939139)
21. Cholinesterase in red cells. Kinyon GE N Engl J Med; 1969 Mar; 280(13):729-30. PubMed ID: 5766090 [No Abstract] [Full Text] [Related]
22. EYE DROPS AND DIARRHEA. DIARRHEA AS THE FIRST SYMPTOM OF ECHOTHIOPHATE IODIDE TOXICITY. MARKMAN HD; ROSENBERG P; DETTBARN WD N Engl J Med; 1964 Jul; 271():197-8. PubMed ID: 14158360 [No Abstract] [Full Text] [Related]
23. Side effects from use of long-acting cholinesterase inhibitors in young persons. Axelsson U; Nyman KG Acta Ophthalmol (Copenh); 1970; 48(3):396-400. PubMed ID: 5535996 [No Abstract] [Full Text] [Related]
25. Intraocular pressure control with echothiophate iodide in children's eyes with glaucoma after cataract extraction. Kraus CL; Trivedi RH; Wilson ME J AAPOS; 2015 Apr; 19(2):116-8.e1. PubMed ID: 25818282 [TBL] [Abstract][Full Text] [Related]
27. Lcal administration of 1 per cent Ubretid in the handling of glaucoma, myasthenia gravis and esotropia. Ishikawa S; Tsukahara S; Sato Y Ophthalmologica; 1969; 159(4):339-62. PubMed ID: 5393688 [No Abstract] [Full Text] [Related]
28. Anticholinesterase eye drops--need for caution. Kinyon GE N Engl J Med; 1969 Jan; 280(1):53. PubMed ID: 5761726 [No Abstract] [Full Text] [Related]
29. Eye drops and apnea. Kramer LP Can Med Assoc J; 1982 Dec; 127(11):1078-9. PubMed ID: 7139452 [No Abstract] [Full Text] [Related]
30. Systemic side effects with eye drops. Alexander WD Br Med J (Clin Res Ed); 1981 Apr; 282(6273):1359. PubMed ID: 6786494 [No Abstract] [Full Text] [Related]
31. Hazards of succinylcholine administration during electrotherapy. Packman PM; Meyer DA; Verdun RM Arch Gen Psychiatry; 1978 Sep; 35(9):1137-41. PubMed ID: 686974 [TBL] [Abstract][Full Text] [Related]
32. Provocation of bronchospasm by eye drops. Fratto C Ann Intern Med; 1978 Mar; 88(3):362. PubMed ID: 629501 [No Abstract] [Full Text] [Related]
33. [Activities of true and pseudo cholinesterases in the patients with a partial accommodative esotropia under phospholine iodide and Ubretid treatment (author's transl)]. Kusayama M; Terakado R; Mukuno K; Ishikawa S Nippon Ganka Gakkai Zasshi; 1974 Feb; 78(2):93-9. PubMed ID: 4858850 [No Abstract] [Full Text] [Related]
34. Electroconvulsive therapy and the chronic use of pseudocholinesterase-inhibitor (echothiophate iodide) eye drops for glaucoma. A case report. Messer GJ; Stoudemire A; Knos G; Johnson GC Gen Hosp Psychiatry; 1992 Jan; 14(1):56-60. PubMed ID: 1730402 [TBL] [Abstract][Full Text] [Related]
36. Cholinesterase in red cells. Gibbs JW N Engl J Med; 1969 Mar; 280(13):729. PubMed ID: 5766089 [No Abstract] [Full Text] [Related]
37. Lenticular opacities in glaucoma patients receiving echothiophate iodide therapy. Preliminary report. De Roetth A JAMA; 1966 Feb; 195(8):664-6. PubMed ID: 5951770 [No Abstract] [Full Text] [Related]
38. Reduction in plasma cholinesterase levels after prolonged administration of echothiophate iodide eyedrops. Eilderton TE; Farmati O; Zsigmond EK Can Anaesth Soc J; 1968 May; 15(3):291-6. PubMed ID: 5658433 [No Abstract] [Full Text] [Related]
39. Glaucoma, miotic therapy and cataract. V. Studies on the lens in glaucoma eyes after discontinuance of echothiophate (phospholine iodide) therapy. Axelsson U Acta Ophthalmol (Copenh); 1969; 47(4):1049-56. PubMed ID: 5394838 [No Abstract] [Full Text] [Related]